Bone Biologics Corporatio... (BBLG)
0.83
-0.06 (-6.61%)
At close: Mar 03, 2025, 3:59 PM
0.80
-3.94%
After-hours: Mar 03, 2025, 05:28 PM EST
Bone Biologics Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -4.11M | -8.95M | -1.48M | -1.61M | -1.82M | -3.42M | -4.43M | -7.05M | -21.03M | -13.88M | -4.42M | -1.08M | -715.57 | -3.6K | -49.05K | -10.29K | -13.34K |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 50.00 | 96.00 | 96.00 | 700.00 | 4.45K | 280.00 | n/a | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 188.82K | 152.6K | 266.63K | 207.03K | 60K | 49.69K | 516.64K | -584.03K | 3.46M | 3.7M | 256.64K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | n/a | -122.95K | -956.92K | 45K | 66.68K | 208.61K | 212.45K | 938.74K | 71.14K | -106.48K | -903.32K | 35.25K | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | -201.33K | -892.69K | -2.18M | 495.55K | 938.08K | 257.81K | 380.03K | 3.37M | 4.01M | 6.04M | 1.41M | 521.59K | 268.08 | -2.08K | 3.6K | 5.41K | -10.98K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -277.75K | -716.79K | n/a | 6.09M | 498.87K | 909.46K | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | n/a | 132.92K | -168.37K | -320.49K | 399.68K | 143.78K | 145.54K | 938.74K | 144.48K | 87.98K | -903.32K | 35.25K | n/a | n/a | n/a | n/a | n/a |
| Operating Cash Flow | -4.12M | -9.56M | -3.57M | -1.23M | -426.93K | -3.25M | -4.1M | -3.33M | -7.33M | -3.55M | -2.76M | -525.37K | -447.49 | -5.68K | -45.45K | -4.87K | -24.33K |
| Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -504 | -11.9K | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.38K | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.38 | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -504 | 25.48K | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 1.05M | 402.79K | 2.32M | n/a | 2.7M | 3.08M | 2M | 4.91M | 524.53K | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | -3.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 7.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M | n/a | n/a | n/a | 448.61 | 5.68K | 45.45K | 1.79K | 15.3K |
| Financial Cash Flow | 4.42M | 5.04M | 4.43M | 7.9M | 402.79K | 2.32M | 4.37M | 3.4M | 6.83M | 2M | 5.39M | 524.53K | 448.61 | 5.68K | 45.45K | 1.79K | 15.3K |
| Net Cash Flow | 298.56K | -4.51M | 862.95K | 6.68M | -24.14K | -931.23K | 265.1K | 69.9K | -494.73K | -1.55M | 2.66M | 1.04K | 1.12 | n/a | n/a | -3.08K | -9.02K |
| Free Cash Flow | -4.12M | -9.56M | -3.57M | -1.23M | -426.93K | -3.25M | -4.1M | -3.33M | -7.33M | -3.55M | -2.77M | -525.37K | -447.49 | -5.68K | -45.45K | -4.87K | -24.33K |